1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Immutep Limited
  6. Financials
    IMM   AU000000IMM6

IMMUTEP LIMITED

(IMM)
  Report
Delayed Australian Stock Exchange  -  05/23 02:10:40 am EDT
0.4000 AUD   +1.27%
05/20Immutep to Present at Investor Conferences
AQ
05/18Immutep appoints leading oncologists to its Clinical Advisory Board
AQ
05/17Immutep Limited Announces Executive Changes
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Capitalization1 84,775,6411337--
Enterprise Value (EV)1 75,858,3351290282320
P/E ratio -4,39x-4,61x-10,9x-6,84x-6,48x-11,1x
Yield ------
Capitalization / Revenue 11,3x4,58x-129x184x51,1x
EV / Revenue 10,1x3,53x-111x154x48,5x
EV / EBITDA -4,14x--20,0x-8,18x-7,50x-18,9x
Price to Book ---3,76x4,62x5,27x
Nbr of stocks (in thousands) 338 860487 631748 153854 123--
Reference price (AUD) 0,250,160,550,400,400,40
Announcement Date 08/20/201908/25/202008/30/2021---
1 AUD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net sales1 7,4916,5-2,631,836,60
EBITDA1 -18,3--17,6-35,5-37,6-16,9
Operating profit (EBIT)1 -20,2-12,3-19,7-37,3-42,4-15,3
Operating Margin -270%-74,6%--1 421%-2 311%-231%
Pre-Tax Profit (EBT)1 -18,3-13,5-29,9-37,4-42,3-15,2
Net income1 -18,3-13,5-29,9-37,3-42,3-15,4
Net margin -245%-81,6%--1 422%-2 309%-233%
EPS2 -0,06-0,03-0,05-0,06-0,06-0,04
Dividend per Share ------
Announcement Date 08/20/201908/25/202008/30/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales1 ---3,20--
EBITDA1 -9,34-8,24--16,2--
Operating profit (EBIT)1 -10,4-9,26-16,1-18,9-18,5-17,3
Operating Margin ----589%--
Pre-Tax Profit (EBT)1 -19,8-10,1-16,3-19,4-18,4-17,2
Net income1 -19,8-10,1-16,3-19,0-18,4-17,2
Net margin ----592%--
EPS2 -0,04-0,01-0,02-0,02-0,03-0,03
Dividend per Share ------
Announcement Date 02/23/202108/30/202102/23/2022---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 8,9317,360,647,055,017,5
Leverage (Debt / EBITDA) 0,49x-3,45x1,32x1,46x1,04x
Free Cash Flow1 -15,3-10,9-17,7-36,2-38,3-25,2
ROE (Net Profit / Equities) ---56,1%-44,2%-57,2%-50,5%
Shareholders' equity1 --53,384,574,030,4
ROA (Net Profit / Asset) ---46,5%-51,7%-65,8%-87,3%
Assets1 --64,372,264,317,6
Book Value Per Share2 ---0,110,090,08
Cash Flow per Share2 ---0,03---0,10
Capex1 0,040,020,020,000,010,01
Capex / Sales 0,55%0,12%-0,18%0,36%0,13%
Announcement Date 08/20/201908/25/202008/30/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Key data
Capitalization (AUD) 337 378 506
Capitalization (USD) 237 072 944
Net sales (AUD) 3 862 806
Net sales (USD) 2 714 360
Free-Float 97,0%
Free-Float capitalization (AUD) 327 190 706
Free-Float capitalization (USD) 229 914 065
Avg. Exchange 20 sessions (AUD) 552 844
Avg. Exchange 20 sessions (USD) 388 479
Average Daily Capital Traded 0,16%
EPS & Dividend